This content is machine translated Acute myeloid leukemia Treatment decisions between MRD monitoring, transplantation and CAR-T cells As part of the SOHC 2025 (Swiss Oncology & Hematology Congress), Christoph Röllig from Dresden University Hospital gave a presentation on current developments in the diagnosis and treatment of minimal...…
View Post 7 min This content is machine translated Chronic inflammation as a driver of ageing Immunosenescence and inflammaging Immunosenescence and inflammaging are now regarded as central biological mechanisms of ageing. The age-related altered immune system is both weakened and chronically activated – with consequences for susceptibility to infection,...…
View Post 12 min This content is machine translated Endometrial carcinoma, malignant melanoma and NSCLC in focus Personalized mRNA and neoantigen vaccines in oncology mRNA technology has experienced its global breakthrough as a result of the COVID-19 pandemic and has long been clinically established. In oncology, however, the actual translation is only now beginning....…
View Post 4 min This content is machine translated From symptom to diagnosis Oncocytoma While renal cell carcinoma (RCC ) is the most common malignant tumor of the kidneys, accounting for around 90% of cases, oncocytoma is the rarest benign tumor of the kidneys...…
View Post 17 min This content is machine translated Low grade serous ovarian carcinoma (LGSOC) Opening up new horizons through combination therapies This year’s congress of the European Society for Medical Oncology , which took place in Berlin from October 17 to 21, 2025, offered an impressive variety of topics on numerous...…
View Post 4 min This content is machine translated Case Report 76-year-old patient with pustular skin rash The efficacy of spesolimab in the treatment of generalized pustular psoriasis (GPP) is well documented in the literature. In the present case study, spesolimab therapy was administered in parallel with...…
View Post 5 min This content is machine translated Oncolytic virus in stage II melanoma Innovative method for predicting therapy response Until now, it was assumed that TVEC works by activating T cells. However, in a study by British and US scientists published in JCO Oncology Advances, the T cell populations...…
View Post 6 min This content is machine translated Oncology Study updates from the ESMO Congress The variety of topics presented at the congress of the European Society for Medical Oncology (ESMO) last October underlined the breadth of the field and the close interlinking of disciplines....…
View Post 9 min This content is machine translated Colorectal cancer screening Results of the population-based PREEMPT-CRC study An original investigational paper published in JAMA 2025 reports the clinical validation of an investigational, blood-based circulating tumor DNA (ctDNA) test for the early detection of colorectal cancer at average...…
View Post 4 min This content is machine translated Study report: Nicotinamide for skin cancer prevention Cohort study analyzed data from over 30,000 patients In the US cohort study published in JAMA Dermatology 2025, the risk of non-melanocytic skin cancer (NMSC) was reduced in patients who had received nicotinamide supplementation – especially if the...…
View Post 7 min This content is machine translated Longevity Medicine 2025 From anti-ageing to precision prevention Longevity Medicine in 2025 is less a marketing term than a clinical work program: moving away from fuzzy “anti-aging” promises towards measurable risk, biomarker and intervention logic. Drivers are a...…
